MarketPulse

board reappointment

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Agomab Therapeutics Wins Shareholder Approval, Confirms 2026 Outlook

Agomab Therapeutics wins unanimous shareholder approval at May 26 AGM, confirms 2026 guidance amid stable biotech leadership transition.
AGMBfinancial resultsAnnual General Meeting
GlobeNewswire Inc.GlobeNewswire Inc.··Stmicroelectronics

STMicroelectronics Charts Shareholder Returns, Expands China Production

STMicroelectronics proposes $0.36 annual dividend, board continuity, and share buyback authorization for 2026 AGM, while expanding China microcontroller production.
STMAnnual General Meetingdividend distribution